| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRI | Common Stock | Options Exercise | $746K | +17.5K | +4.17% | $42.61 | 437K | Nov 29, 2021 | Direct | F1, F2 |
| transaction | CRI | Common Stock | Sale | -$1.83M | -17.5K | -4.01% | $104.35 | 419K | Nov 29, 2021 | Direct | F1, F2, F3 |
| transaction | CRI | Common Stock | Sale | -$1.33M | -12.6K | -3% | $105.62 | 407K | Nov 29, 2021 | Direct | F1, F2, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRI | Employee Stock Option (Right to Purchase) | Options Exercise | $0 | -17.5K | -100% | $0.00* | 0 | Nov 29, 2021 | Common Stock | 17.5K | $42.61 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The transaction reported in this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan |
| F2 | Some of these shares are restricted shares that are subject to either time-vesting or performance-based restrictions. |
| F3 | This is a weighted average price. The shares were sold in multiple trade executions at prices ranging from $103.50 to $105.35 inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| F4 | This is a weighted average price. The shares were sold in multiple trade executions at prices ranging from $105.15 to $106.00 inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| F5 | The option vested in four equal installments on February 22, 2013, 2014, 2015, and 2016. |